Tamsulosin Hydrochloride Capsule
Product Images NDC 50090-3646

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 50090-3646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903646)

Tamsulosin Hydrochloride 0.4 mg capsules label by A-S Medication Solutions. The label indicates each capsule contains 0.4 mg of tamsulosin hydrochloride USP, 0.4 mg. The package contains 30 capsules. Storage instructions advise keeping at 20°C to 25°C (68°F to 77°F) and avoiding excessive moisture.*

FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

A line graph showing plasma concentration (ng/mL) of a substance over time (hours) under two conditions: fasted (dashed line) and fed (solid line). The graph depicts higher peak concentration and faster rise in the fasted state compared to the fed state, with gradual decline after peak in both conditions.*

FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

This line graph depicts mean change over weeks in a treatment study comparing Tamsulosin Hydrochloride 0.4 mg, 0.8 mg, and placebo groups. The x-axis represents the duration of treatment in weeks, while the y-axis shows mean change values. The graph includes markers for group sizes at each time point and illustrates differences between treatment and placebo over time.*

FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

A line graph depicting mean change over the duration of treatment in weeks for Tamsulosin Hydrochloride at doses of 0.4 mg and 0.8 mg compared to placebo. The x-axis indicates treatment duration in weeks from 0 to 13, and the y-axis shows mean change values, illustrating trends of treatment effects over time.*

FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

A line graph depicting mean change in a measured variable (mL/sec) over duration of treatment in weeks, comparing three groups: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis shows the duration from 0 to 13 weeks plus LOCE, and the y-axis shows mean change values ranging from 0 to 3 mL/sec. Data points are plotted for each group at multiple time intervals.*

FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

A line graph depicting mean change in mL/sec over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg doses of Tamsulosin Hydrochloride, and a placebo group. The x-axis represents treatment duration from 0 to 13 weeks, and the y-axis shows mean change ranging from 0 to 3 mL/sec. Different line styles and markers distinguish the treatments.*

FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

Chemical structure of Tamsulosin Hydrochloride, the active ingredient in Tamsulosin Hydrochloride capsules. The structure shows aromatic rings, methoxy and sulfonamide groups, and the hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.